Backed by big-name VCs, this startup is turning machine learning on drug discovery

Daphne Koller, the former ed-tech entrepreneur who jumped to anti-aging drug research company Calico, is launching a company turning machine learning on drug discovery and development with the backing of prominent biotech venture capital firms at the intersection of tech and biotech. Not much is known at this point about Insitro, backed by Foresite Capital, Alphabet investment arm GV, Third Rock Ventures, Andreessen Horowitz and ARCH Ventures. But the company's website says it will apply machine…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news